Moneycontrol PRO
Upcoming Webinar:Prashant Shah explains ‘Irrelevance of Bull & Bear Markets for Success in Technical Analysis’. Register For Free!

COVID crisis | CAIT lauds Mukesh Ambani, Ratan Tata, Naveen Jindal for helping India with oxygen supply

Bhartia and Khandelwal said that these big corporates have “proved that they are the sons of the soil and have come forward to help the country at a time when the entire nation was worried about the shortage of medical oxygen”.

April 25, 2021 / 09:22 PM IST
Several big corporates in India have come forward to help arrange for medical oxygen at a time of crisis

Several big corporates in India have come forward to help arrange for medical oxygen at a time of crisis


The Confederation of All India Traders (CAIT) has lauded leading industrialists of India and the Chief of Government Undertakings for helping India with medical oxygen supply during the COVID-19 crisis the country is reeling under in the wake of the second wave of the pandemic.

CAIT National President BC Bhartia and Secretary General Praveen Khandelwal said that at the instance of Prime Minister Narendra Modi, several top industrialists of India came forward to arrange an uninterrupted supply of medical oxygen.

Leading industrialists of India such as Reliance Industries Chairman Mukesh Ambani, Ratan Tata of Tata Group, Jindal Steel Chairman Naveen Jindal, Vedanta Group Chairman Anil Agarwal, Indian Oil Chairman Madhav Vaidya, Bharat Petroleum Chairman K Padmakar, SAIL Chairman Soma Mondal, Sajjan Jindal of JSW, and played a commendable role, CAIT said on April 25.

Bhartia and Khandelwal said that these big corporates have “proved that they are the sons of the soil and have come forward to help the country at a time when the entire nation was worried about the shortage of medical oxygen”.

They added: “We might have some differences with corporate India but at a time when these people have stood up for the nation, extending gratitude to them is all the more necessary.”

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
CAIT pointed out: “At this critical time no foreign MNCs have come forward to help the nation from which they are earning huge revenue and even adopting malpractices and violating the law and trying to control and capture the trade and commerce.”







Disclaimer: MoneyControl is a part of the Network18 group. Network18 is controlled by Independent Media Trust, of which Reliance Industries is the sole beneficiary.






Moneycontrol News

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark